Results 241 to 248 of about 32,467 (248)

Sparfloxacin, a New Generation Fluoroquinolone against S. pneumoniae Respiratory Infections

Drugs, 1995
Y, Niki, S, Tamada, M, Nakabayashi, R, Soejima   +3 more
openaire   +2 more sources

Fluoroquinolones in ambulatory ENT and respiratory tract infections: rarely appropriate.

Prescrire international, 2003
(1) The risk-benefit ratio of antibiotic therapy in exacerbations of chronic bronchitis is uncertain. If an antibiotic is considered, fluoroquinolones are at best second-line options, after betalactam agents such as amoxicillin, and macrolides. (2) For community-acquired pneumonia the first-line antibiotics are betalactam agents such as amoxicillin ...
openaire   +1 more source

[Other communal respiratory pathogens and new fluoroquinolones].

Enfermedades infecciosas y microbiologia clinica, 1999
R, Cantón, E, Loza, S, Valdezate, F, Baquero   +3 more
openaire   +1 more source

CLINICAL ROLE OF FLUOROQUINOLONES IN PATIENTS WITH RESPIRATORY TRACT INFECTIONS

Infectious Diseases in Clinical Practice, 1999
Richard Quintiliani, Robert C. Owens, Edward M. Grant   +2 more
openaire   +1 more source

Levofloxacin in treatment of respiratory tract infections fluoroquinolones, levofloxacin, respiratory tract infection

Forum Zakażeń, 2015
openaire   +1 more source

[Fluoroquinolones in the treatment of respiratory infections].

Pneumologie (Stuttgart, Germany), 2000
openaire   +1 more source

Respiratory fluoroquinolone monotherapy for community-acquired pneumonia: a revised trial sequential analysis

International Journal of Antimicrobial Agents
Hsiu-Jung Lin, I-Wen Chen, Kuo-Mao Lan, Kuo-Chuan Hung   +3 more
openaire   +2 more sources

[Comparative characteristics of respiratory fluoroquinolones registered in Russia].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003
openaire   +1 more source